Clinic
Mercy Health System Corporation
Mercy Health System Corporation was paid $13.19M by Medicaid between Jan 2018 and Dec 2024, across 212 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoMERCY HEALTH SYSTEM CORPORATION
JANESVILLE, WI 53548
JANESVILLE, WI 53548
33aNPI1598718603assigned 05/18/2006
33bProvider typeClinic/Center
28Total paid$13.19M
24GClaims535,177
24DCodes billed212
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Wisconsin
Rank by total paid#2 of 102
Median peer was paid$54K
This provider vs. median246×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MALAS, JOSEPH controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,396 | $1.96M | |
| 2019 | 78,589 | $1.82M | |
| 2020 | 65,298 | $1.58M | |
| 2021 | 78,928 | $1.88M | |
| 2022 | 81,138 | $1.95M | |
| 2023 | 83,632 | $2.01M | |
| 2024incomplete | 59,196 | $2.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 93,003 | 84,682 | $3.33M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 100,632 | 90,812 | $2.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.5% | 28,729 | 26,859 | $599K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 9,756 | 8,856 | $562K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3.4% | 11,476 | 10,892 | $454K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.1% | 6,896 | 6,736 | $409K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 2.9% | 18,197 | 17,168 | $381K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.9% | 15,362 | 14,274 | $380K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.9% | 6,182 | 5,318 | $252K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 5,028 | 4,753 | $244K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 2,597 | 2,393 | $232K |
| 92015 | Determination of refractive state | 1.5% | 21,632 | 20,349 | $199K |
200 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 4,375 | $194K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 3,284 | $193K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 5,398 | $183K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 13,743 | $172K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.3% | 30,051 | $168K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.2% | 3,880 | $153K |
| 99285 | Emergency room visit (most serious) | 1.1% | 5,113 | $147K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,004 | $119K |
| 98940 | <1% | 9,158 | $113K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,706 | $108K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,456 | $97K |
| 92341 | <1% | 3,631 | $97K | |
| 64483 | <1% | 797 | $95K | |
| 71045 | Radiologic examination, chest; single view | <1% | 19,416 | $93K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 7,342 | $78K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,502 | $76K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,057 | $62K |
| 90686 | <1% | 7,676 | $55K | |
| 95886 | <1% | 826 | $55K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 601 | $51K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,233 | $49K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,162 | $48K |
| J2357 | Injection, omalizumab, 5 mg | <1% | 78 | $47K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 241 | $40K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 937 | $37K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,126 | $35K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,326 | $34K |
| 92133 | <1% | 1,290 | $34K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 397 | $33K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,442 | $31K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,473 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 569 | $28K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 331 | $27K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 732 | $27K |
| 90670 | <1% | 5,446 | $24K | |
| 73630 | <1% | 1,422 | $23K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 490 | $21K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 747 | $21K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 470 | $20K |
| 90723 | <1% | 3,419 | $20K | |
| 90647 | <1% | 3,246 | $19K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 55 | $19K |
| 92134 | <1% | 1,252 | $17K | |
| 98927 | <1% | 717 | $16K | |
| 11721 | <1% | 1,140 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 291 | $13K |
| 90677 | <1% | 809 | $12K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 749 | $11K |
| 00731 | <1% | 188 | $9K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 186 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 231 | $9K |
| 90961 | <1% | 133 | $8K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 99 | $8K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 407 | $8K |
| 99242 | <1% | 204 | $8K | |
| 17110 | <1% | 438 | $8K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 234 | $7K |
| 93298 | <1% | 474 | $7K | |
| 73562 | <1% | 427 | $7K | |
| 0002A | <1% | 219 | $7K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 519 | $7K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 188 | $7K |
| 0001A | <1% | 238 | $7K | |
| 99219 | <1% | 197 | $7K | |
| 0071A | <1% | 173 | $6K | |
| 20610 | <1% | 148 | $6K | |
| 99223 | Prolong inpt eval add15 m | <1% | 157 | $6K |
| 94729 | <1% | 237 | $6K | |
| 95910 | <1% | 72 | $6K | |
| 95115 | <1% | 1,873 | $6K | |
| 90656 | <1% | 366 | $6K | |
| 90633 | <1% | 1,097 | $6K | |
| 90837 | Psychotherapy session, about an hour | <1% | 66 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,997 | $5K |
| 94726 | <1% | 201 | $5K | |
| 74018 | <1% | 504 | $5K | |
| 92202 | <1% | 1,042 | $5K | |
| 72100 | <1% | 266 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 150 | $5K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 94 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 340 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 149 | $4K |
| 90710 | <1% | 718 | $4K | |
| 94060 | <1% | 117 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 468 | $4K |
| 96367 | <1% | 118 | $4K | |
| 91321 | <1% | 27 | $4K | |
| 59025 | Fetal non-stress test | <1% | 126 | $4K |
| 95811 | <1% | 43 | $4K | |
| 80305 | <1% | 472 | $4K | |
| 0072A | <1% | 90 | $4K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $3K |
| 96137 | <1% | 37 | $3K | |
| 92310 | <1% | 14 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 297 | $3K |
| 93016 | <1% | 227 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 99 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 67 | $3K |
| 90681 | <1% | 471 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 57 | $3K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 90 | $3K |
| 94010 | <1% | 79 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 55 | $3K |
| 92226 | <1% | 355 | $2K | |
| 90651 | <1% | 481 | $2K | |
| 99243 | <1% | 39 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 367 | $2K |
| 93018 | <1% | 227 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 98 | $2K |
| 73030 | <1% | 152 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 191 | $2K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 24 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 230 | $2K |
| 96127 | <1% | 694 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 47 | $2K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 40 | $2K |
| 0004A | <1% | 44 | $2K | |
| 87486 | <1% | 55 | $2K | |
| 87581 | <1% | 55 | $2K | |
| 36591 | <1% | 241 | $2K | |
| 99460 | <1% | 16 | $2K | |
| 76881 | <1% | 24 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 29 | $1K |
| 88342 | <1% | 48 | $1K | |
| 90734 | <1% | 369 | $1K | |
| 92557 | <1% | 41 | $1K | |
| 96136 | <1% | 52 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 237 | $1K |
| 96132 | <1% | 15 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 29 | $1K |
| 90671 | <1% | 73 | $1K | |
| 90480 | <1% | 28 | $1K | |
| 3008F | <1% | 364 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 493 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 28 | $1K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 14 | $964.69 |
| 80061 | Lipid panel | <1% | 93 | $964.66 |
| 88307 | <1% | 15 | $902.90 | |
| 95908 | <1% | 13 | $898.00 | |
| 97162 | <1% | 14 | $828.05 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $823.63 |
| 87634 | <1% | 13 | $785.15 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 26 | $775.68 |
| 99152 | <1% | 30 | $740.59 | |
| 31231 | <1% | 14 | $730.93 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,716 | $705.25 |
| 93295 | <1% | 26 | $667.91 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $652.10 |
| 80050 | General health panel | <1% | 12 | $617.28 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $574.89 |
| 99443 | <1% | 46 | $558.54 | |
| 99173 | <1% | 28 | $532.00 | |
| 80076 | <1% | 60 | $528.36 | |
| 95819 | <1% | 16 | $510.02 | |
| 87210 | <1% | 92 | $504.66 | |
| 93793 | <1% | 123 | $500.10 | |
| 92225 | <1% | 30 | $474.88 | |
| 73110 | <1% | 27 | $433.06 | |
| 81001 | <1% | 154 | $429.54 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $413.59 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 18 | $406.53 |
| 85027 | <1% | 58 | $391.59 | |
| 73610 | <1% | 28 | $386.60 | |
| 93296 | <1% | 26 | $374.12 | |
| 73130 | <1% | 17 | $373.25 | |
| 84478 | <1% | 60 | $364.60 | |
| 51798 | <1% | 37 | $321.69 | |
| 88304 | <1% | 41 | $313.82 | |
| 95012 | <1% | 30 | $298.23 | |
| 90715 | <1% | 125 | $287.97 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $270.20 |
| 20611 | <1% | 14 | $256.61 | |
| 88312 | <1% | 14 | $246.83 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 326 | $227.50 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 27 | $226.82 |
| 93000 | <1% | 13 | $217.33 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 40 | $216.66 |
| 81003 | <1% | 88 | $191.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 381 | $186.81 |
| 96160 | <1% | 90 | $172.97 | |
| 97035 | <1% | 20 | $157.88 | |
| 92552 | <1% | 13 | $153.20 | |
| 76937 | <1% | 16 | $150.81 | |
| 93294 | <1% | 13 | $140.73 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 55 | $117.58 |
| 83986 | <1% | 26 | $115.63 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 29 | $101.99 |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 32 | $94.95 |
| 88313 | <1% | 13 | $92.62 | |
| 90696 | <1% | 77 | $89.37 | |
| 90620 | <1% | 14 | $46.34 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,202 | $39.65 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 18 | $22.83 |
| 93325 | <1% | 15 | $17.45 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,576 | $10.31 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 7,547 | $0.14 |
| 99172 | 0% | 76 | $0.00 | |
| 98960 | 0% | 31 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 27 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALAS, JOSEPH (CFO - AUTHORIZED OFFICIAL)
Parent organizationMERCY HEALTH CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Mercy Health System Corporation | Janesville, WI | $25.46M |
| Genesis Health System | Davenport, IA | $23.22M |
| Mercy Health System Corporation | Lake Geneva, WI | $9.39M |
| Mercy Health System Corporation | Janesville, WI | $8.15M |
| Mercy Assisted Care, INC | Janesville, WI | $4.04M |
| Genesis Medical Center, Aledo | Aledo, IL | $3.62M |
| Freeport Memorial Hospital | Freeport, IL | $1.40M |
| Javon Bea Hospital | Rockford, IL | $1.23M |
| Mercy Health System Corporation | Janesville, WI | $1.17M |
| Mercy Assisted Care, INC | Harvard, IL | $601K |
| Mercyhealth Visiting Nurses Association, INC | Rockford, IL | $251K |
| Javon Bea Hospital | Rockford, IL | $174K |
| Genesis Health System | De Witt, IA | $136K |
| Mercy Assisted Care, INC | Janesville, WI | $136K |
| Genesis Health System | Bettendorf, IA | $32K |
| Mercy Assisted Care, INC | Janesville, WI | $12K |
| Mercy Harvard Hospital INC | Harvard, IL | $10K |
| Rockford Health Physicians | Rockford, IL | $9K |
| Mercy Health System Corporation | Janesville, WI | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.